• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Retinoblastoma: correlation between age at diagnosis and survival.

作者信息

Abramson D H, Ellsworth R M, Grumbach N, Sturgis-Buckhout L, Haik B G

出版信息

J Pediatr Ophthalmol Strabismus. 1986 Jul-Aug;23(4):174-7. doi: 10.3928/0191-3913-19860701-06.

DOI:10.3928/0191-3913-19860701-06
PMID:3746592
Abstract

Life tables analyses were performed from the records of 1147 patients seen between 1958 and 1983 to determine correlation between age at diagnosis and survival from metastatic retinoblastoma. No difference was noted overall in survival from metastatic retinoblastoma for unilateral vs. bilateral, male vs female, or family history vs negative family history. Survival rate of 21 of 40 patients diagnosed after age 7 and receiving no treatment was 96%. Two patients in this group did develop metastasis: one because of late diagnosis and one because treatment was refused. One patient with an "arrested retinoblastoma" showed growth in his third decade, necessitating treatment. Survival was poorest in patients diagnosed between ages two and seven years where mortality was 19% from metastatic retinoblastoma. Patients diagnosed between birth and two years had an intermediate survival of 95%. Because of second nonocular tumors, survival of the patient with unilateral retinoblastoma was significantly better than that of the bilaterally affected child.

摘要

相似文献

1
Retinoblastoma: correlation between age at diagnosis and survival.
J Pediatr Ophthalmol Strabismus. 1986 Jul-Aug;23(4):174-7. doi: 10.3928/0191-3913-19860701-06.
2
Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983.
J Pediatr Ophthalmol Strabismus. 1985 Nov-Dec;22(6):246-50. doi: 10.3928/0191-3913-19851101-11.
3
Retinoblastoma treated in infants in the first six months of life.
Arch Ophthalmol. 1983 Sep;101(9):1362-6. doi: 10.1001/archopht.1983.01040020364004.
4
Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?视网膜母细胞瘤幸存者中的第二种非眼部肿瘤。它们是辐射诱发的吗?
Ophthalmology. 1984 Nov;91(11):1351-5. doi: 10.1016/s0161-6420(84)34127-6.
5
Retinoblastoma in the first year of life.
Ophthalmic Paediatr Genet. 1992 Dec;13(4):191-203. doi: 10.3109/13816819209105167.
6
Retinoblastoma: presentation and survival in Negro children compared with whites.视网膜母细胞瘤:黑人儿童与白人儿童的临床表现及生存率比较
J Natl Cancer Inst. 1972 Oct;49(4):989-92.
7
Retinoblastoma with anterior chamber extension.伴有前房扩展的视网膜母细胞瘤。
Ophthalmology. 1987 Apr;94(4):367-70. doi: 10.1016/s0161-6420(87)33437-2.
8
Prolonged survival of a child with metastatic retinoblastoma.一名患有转移性视网膜母细胞瘤儿童的长期存活。
J Pediatr Ophthalmol Strabismus. 1987 Sep-Oct;24(5):247-8. doi: 10.3928/0191-3913-19870901-12.
9
[Retinoblastoma: clinical and molecular diagnostic aspects].[视网膜母细胞瘤:临床与分子诊断方面]
Praxis (Bern 1994). 1996 Aug 27;85(35):1058-62.
10
Retinoblastoma: the Saudi Arabian experience.视网膜母细胞瘤:沙特阿拉伯的经验
Ophthalmic Paediatr Genet. 1988 Jul;9(2):115-9. doi: 10.3109/13816818809031484.

引用本文的文献

1
Association of Neighborhood Opportunity With Severity of Retinoblastoma at Presentation.社区机会与视网膜母细胞瘤就诊时严重程度的关联。
Am J Ophthalmol. 2024 May;261:1-6. doi: 10.1016/j.ajo.2024.01.013. Epub 2024 Jan 15.
2
Recent advancements in the management of retinoblastoma and uveal melanoma.视网膜母细胞瘤和葡萄膜黑色素瘤治疗的最新进展。
Fac Rev. 2021 May 28;10:51. doi: 10.12703/r/10-51. eCollection 2021.
3
Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion.
黏附 G 蛋白偶联受体,ELTD1,是治疗视网膜母细胞瘤迁移和侵袭的潜在靶点。
BMC Cancer. 2021 Jan 11;21(1):53. doi: 10.1186/s12885-020-07768-3.
4
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.大龄儿童(>5 岁)视网膜母细胞瘤的经动脉化疗治疗:与化疗前和静脉化疗时代的结局比较。
Indian J Ophthalmol. 2019 Dec;67(12):2005-2011. doi: 10.4103/ijo.IJO_642_19.
5
Presenting signs of retinoblastoma at a tertiary level teaching hospital in Ethiopia.埃塞俄比亚一家三级教学医院视网膜母细胞瘤的临床表现
Pan Afr Med J. 2017 Sep 22;28:66. doi: 10.11604/pamj.2017.28.66.11199. eCollection 2017.
6
Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.在视网膜母细胞瘤的体外模型中,抑制基质金属蛋白酶-2(MMP-2)和基质金属蛋白酶-9(MMP-9)可减少细胞迁移和血管生成。
BMC Cancer. 2017 Jun 20;17(1):434. doi: 10.1186/s12885-017-3418-y.
7
Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.阿柏西普在视网膜母细胞瘤体外和体内模型中的疗效与安全性
J Exp Clin Cancer Res. 2016 Nov 4;35(1):171. doi: 10.1186/s13046-016-0451-7.
8
Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran.伊朗西北部儿童视网膜母细胞瘤的特征与临床表现
Int J Ophthalmol. 2012;5(4):510-2. doi: 10.3980/j.issn.2222-3959.2012.04.20. Epub 2012 Aug 18.
9
Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.肿瘤血管生成作为视网膜母细胞瘤疾病播散的一个预后因素。
Br J Ophthalmol. 2003 Oct;87(10):1224-8. doi: 10.1136/bjo.87.10.1224.
10
Retinoblastoma. Continuum of care.视网膜母细胞瘤。连续护理。
Can Fam Physician. 1993 Jun;39:1470-1.